We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$676M
AUM Growth
+$13.1M
Cap. Flow
-$23.3M
Cap. Flow %
-3.45%
Top 10 Hldgs %
35.88%
Holding
700
New
222
Increased
104
Reduced
125
Closed
228

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$37.9M
2
MSFT icon
Microsoft
MSFT
+$36.5M
3
NVDA icon
NVIDIA
NVDA
+$29.1M
4
ALV icon
Autoliv
ALV
+$27.7M
5
TECK icon
Teck Resources
TECK
+$21.4M

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$121M
2
BABA icon
Alibaba
BABA
+$15.7M
3
MELI icon
Mercado Libre
MELI
+$14.3M
4
AMD icon
Advanced Micro Devices
AMD
+$13.1M
5
SE icon
Sea Limited
SE
+$13M

Sector Composition

Rank Sector Weight
1 Technology 33.65%
2 Consumer Discretionary 17.78%
3 Healthcare 10.68%
4 Financials 10.41%
5 Industrials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVX
676
Innovex International
INVX
$1.97B
-24,120
Closed -$692K
TBCH
677
Turtle Beach Corp
TBCH
$277M
-13,288
Closed -$133K
QVCGA
678
DELISTED
QVC Group Inc Series A
QVCGA
-4,092
Closed -$202K
JOYY
679
JOYY Inc
JOYY
$3.75B
-25,389
Closed -$792K
AMPS
680
DELISTED
Altus Power
AMPS
-19,392
Closed -$106K
ATSG
681
DELISTED
Air Transport Services Group
ATSG
-16,287
Closed -$339K
LGTY
682
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-14,791
Closed -$187K
PSTX
683
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-24,608
Closed -$75.8K
GRTS
684
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-87,786
Closed -$244K
TUP
685
DELISTED
Tupperware Brands Corporation
TUP
-93,529
Closed -$234K
TWOU
686
DELISTED
2U Inc
TWOU
-737
Closed -$151K
CONN
687
DELISTED
Conn's Inc.
CONN
-16,384
Closed -$99.3K
MODN
688
DELISTED
MODEL N, INC.
MODN
-14,724
Closed -$493K
KAMN
689
DELISTED
Kaman Corp
KAMN
-10,494
Closed -$240K
CBAY
690
DELISTED
Cymabay Therapeutics
CBAY
-25,725
Closed -$224K
NEWR
691
DELISTED
New Relic, Inc.
NEWR
-3,643
Closed -$274K
ICPT
692
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-85,544
Closed -$1.15M
SCPL
693
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
-15,882
Closed -$269K
RAD
694
DELISTED
Rite Aid Corporation
RAD
-55,221
Closed -$124K
BKI
695
DELISTED
Black Knight, Inc. Common Stock
BKI
-8,219
Closed -$473K
PDCE
696
DELISTED
PDC Energy, Inc.
PDCE
-8,100
Closed -$520K
ARCH
697
DELISTED
Arch Resources, Inc.
ARCH
-3,800
Closed -$500K
ATVI
698
DELISTED
Activision Blizzard
ATVI
-13,526
Closed -$1.16M
DISH
699
DELISTED
DISH Network Corp.
DISH
-90,956
Closed -$849K
YELL
700
DELISTED
Yellow Corporation Common Stock
YELL
-148,839
Closed -$302K

Similar funds

Caxton Associates (New York)'s Q2 2023 Portfolio in Review

As of Q2 2023, Caxton Associates (New York) held 700 positions worth $676M, up 2% from $663M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Caxton Associates (New York) withdrew a net $23.3M in Q2 2023, closing 228 positions and reducing 125 holdings. Its most notable exit was Freeport-McMoran, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Caxton Associates (New York) opened a new position in Amazon worth $43.2M.

  • Caxton Associates (New York)'s largest Q2 2023 buy was Amazon: 331,495 shares worth $43.2M.
  • Caxton Associates (New York) added most to NVIDIA in Q2 2023, an estimated $29.1M increase.
  • Caxton Associates (New York)'s biggest Q2 2023 reduction was Alibaba, cutting an estimated $15.7M.
  • Caxton Associates (New York) fully exited Freeport-McMoran in Q2 2023, selling an estimated $121M.
  • Caxton Associates (New York)'s ten largest holdings make up 36% of its $676M portfolio in Q2 2023.
  • Caxton Associates (New York) opened 222 new positions and closed 228 in Q2 2023.
  • Caxton Associates (New York)'s portfolio value rose 2% quarter-over-quarter to $676M.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.